# The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)

> **NCT00856960** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 12 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Aliskiren
- **DRUG:** Aliskiren
- **DRUG:** Comparator: Losartan
- **DRUG:** Comparator: Placebo to Aliskiren
- **DRUG:** Comparator: Placebo to Losartan

## Key facts

- **NCT ID:** NCT00856960
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00856960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00856960, "The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00856960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*